FDA Approval Insights: Selinexor in Relapsed/Refractory DLBCL
Season 3, Episode 50, Oct 26, 2020, 08:50 PM
In our exclusive interview, Brian T. Hill, MD, PhD, provides perspective on the FDA approval of selinexor in DLBCL.
In our exclusive interview, Brian T. Hill, MD, PhD, provides perspective on the FDA approval of selinexor in DLBCL.
You can visit our support center if you're having problems.